Search results

Selected filters:

News
Litigation

Article type

Topic

Sector

Regions

Year

454 results found for your search

Sort options
13 September 2019

Patent litigation is one reason why the UK will remain in the legal premier league

Despite the pervading sense of gloom, the quality of English courts and lawyers - and the remedies now available to plaintiffs - mean that there is an IP bright spot amidst the carnage of Brexit

11 September 2019

Software IP issues for universities have never been more complex, says tech commercialisation leader

In an exclusive interview with IAM, given in the run-up to Software IP 2019, the University of Chicago's George Chellapa describes the challenges of the fast-moving sector and how working with industry is crucial

11 September 2019

Five things to watch for from Japan’s new IP policy leadership

The new commissioner of the JPO and top cabinet advisor on IP will both address IPBC Asia in Tokyo in some of their first appearances in front of a global audience

07 September 2019

Life sciences IP - the major developments in August

All the big pharma and biotech patent stories from last month in our regular monthly round-up

28 August 2019

Asia's top IP owners revealed

Big filers, tough litigators and savvy dealmakers identified across eight industries in the run-up to IPBC Asia in Tokyo this October

24 August 2019

Adversaries no more - licensors look to make deals, not settlements

In its day, the IPNav model was hugely successful in generating cash, but successful licensing in the here and now requires a different, less confrontational approach

14 August 2019

USPTO Director Iancu set to keynote IAM’s patent litigation event as 101 legislation debate continues

American Express, Nokia, Google, Nasdaq, Volkswagen, Novartis and Merck executives among the final speakers revealed for prestigious November conference in Washington DC

10 August 2019

A No Deal Brexit now looks unavoidable, so plan accordingly

Boris Johnson becoming Prime Minister has totally changed the trajectory of the UK's departure from the EU and IP owners' strategies should reflect that

03 August 2019

Life sciences IP – the major developments in July

All the big pharma and biotech patent stories from last month in our regular monthly round-up

25 July 2019

Big CAFC decision gives operating companies that transfer patents to NPEs plenty to consider

The Lone Star ruling squarely puts entities that try to monetise their IP by transferring it to third-parties at risk of being joined in any subsequent litigation

23 July 2019

It's security, stupid - why it's time to see the wood from the trees in the FTC's case against Qualcomm

If the US chipmaker’s recent court defeat stands then the US risks ceding to China a central role in the development of 5G and future wireless technology

18 July 2019

Federal Circuit decision shows door not shut on infringement claims under the doctrine of equivalents in ANDA cases

Ruling in UCB v Watson Laboratories provides important strategic guidance on the doctrine for both patent prosecutors and litigators

10 July 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month

09 July 2019

Incorrectly naming an RPI will not derail an IPR, Federal Circuit rules

In Mayne Pharma, the court upheld a PTAB final written decision invalidating a patent despite the owner’s objection that all real-parties-in-interest were not properly named in the original review petition

04 July 2019

Why it's time for a new approach to 5G patent licensing

How a more proactive, collaborative approach by SEP licensors - one that focuses on reaching out to start-ups and SMEs - could lead to a lot more deals and a lot less pain